首页 > 最新文献

British journal of hospital medicine最新文献

英文 中文
Knowledge-Attitude-Practice Toward Standardized Nursing Terminology Among Nurses in a Tertiary Hospital in Southwest China: A Single-Center Cross-Sectional Survey. 西南地区某三级医院护士对规范化护理术语的知识-态度-实践:一项单中心横断面调查
IF 1.8 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-26 DOI: 10.31083/BJHM50395
Huan Feng, Shi Pu, Lingling Chu, Yu Shi

Aims/background: The adoption of standardized nursing terminology (SNT) is crucial for ensuring efficient information delivery and data sharing among nursing staff, as well as effective nursing care. This study aims to assess nurses' Knowledge-Attitude-Practice regarding SNT, and identify key influencing factors of SNT application.

Methods: This study involves the development of a questionnaire for a survey based on the Knowledge-Attitude-Practice (KAP) model, combined with literature research and Delphi method. A cross-sectional survey was conducted among 515 nursing staff from 26 departments.

Results: The resulting questionnaire consisted of 29 items, with a Cronbach's α coefficient of 0.959. The scores for Knowledge-Attitude-Practice of nurses toward SNT were 12.73 ± 4.61, 35.05 ± 5.70, and 31.72 ± 9.93, respectively. Multiple linear regression analysis indicated that the position title, education level and years of work were independent influencing factors of the SNT levels among the surveyed nurses. The three most frequently mentioned barriers by nursing staff were increased workload, insufficient support from information systems, and a lack of nursing informatics professionals.

Conclusion: This study indicates that nursing staff hold positive attitudes toward SNT, but their awareness and practical application remain insufficient. Strengthening competency-based training and urgently optimizing nursing information systems are therefore necessary.

目的/背景:采用标准化护理术语(SNT)对于确保护理人员之间有效的信息传递和数据共享以及有效的护理至关重要。本研究旨在评估护士对SNT的知识-态度-实践,并找出影响SNT应用的关键因素。方法:本研究以知识-态度-实践(Knowledge-Attitude-Practice, KAP)模型为基础,结合文献研究和德尔菲法,编制调查问卷。对我院26个科室515名护理人员进行横断面调查。结果:问卷共29项,Cronbach′s α系数为0.959。护士对SNT的知识-态度-实践得分分别为12.73±4.61分、35.05±5.70分和31.72±9.93分。多元线性回归分析显示,职称、学历、工作年限是影响受访护士SNT水平的独立因素。护理人员最常提到的三个障碍是工作量增加、信息系统支持不足和缺乏护理信息学专业人员。结论:本研究表明护理人员对SNT持积极态度,但意识和实际应用不足。因此,加强以能力为基础的培训和紧急优化护理信息系统是必要的。
{"title":"Knowledge-Attitude-Practice Toward Standardized Nursing Terminology Among Nurses in a Tertiary Hospital in Southwest China: A Single-Center Cross-Sectional Survey.","authors":"Huan Feng, Shi Pu, Lingling Chu, Yu Shi","doi":"10.31083/BJHM50395","DOIUrl":"https://doi.org/10.31083/BJHM50395","url":null,"abstract":"<p><strong>Aims/background: </strong>The adoption of standardized nursing terminology (SNT) is crucial for ensuring efficient information delivery and data sharing among nursing staff, as well as effective nursing care. This study aims to assess nurses' Knowledge-Attitude-Practice regarding SNT, and identify key influencing factors of SNT application.</p><p><strong>Methods: </strong>This study involves the development of a questionnaire for a survey based on the Knowledge-Attitude-Practice (KAP) model, combined with literature research and Delphi method. A cross-sectional survey was conducted among 515 nursing staff from 26 departments.</p><p><strong>Results: </strong>The resulting questionnaire consisted of 29 items, with a Cronbach's α coefficient of 0.959. The scores for Knowledge-Attitude-Practice of nurses toward SNT were 12.73 ± 4.61, 35.05 ± 5.70, and 31.72 ± 9.93, respectively. Multiple linear regression analysis indicated that the position title, education level and years of work were independent influencing factors of the SNT levels among the surveyed nurses. The three most frequently mentioned barriers by nursing staff were increased workload, insufficient support from information systems, and a lack of nursing informatics professionals.</p><p><strong>Conclusion: </strong>This study indicates that nursing staff hold positive attitudes toward SNT, but their awareness and practical application remain insufficient. Strengthening competency-based training and urgently optimizing nursing information systems are therefore necessary.</p>","PeriodicalId":9256,"journal":{"name":"British journal of hospital medicine","volume":"87 1","pages":"50395"},"PeriodicalIF":1.8,"publicationDate":"2026-01-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146084304","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Preliminary Application of Toripalimab in Combination With GEMOX Regimen as a First-Line Treatment Option for Advanced Biliary Tract Tumors. 托里帕利单抗联合GEMOX方案作为晚期胆道肿瘤一线治疗方案的初步应用
IF 1.8 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-22 DOI: 10.31083/BJHM50279
Meiqin Yuan, Wanxia Fang, Bixia Liu, Yahan Tong, Junchi Cheng, Haijun Zhong, Wangxia Lv

Aims/background: Advanced biliary tract cancer (BTC) is an aggressive malignancy, and often presents with poor prognostic outcomes despite standard chemotherapy. This study aimed to evaluate the preliminary efficacy and safety of toripalimab in combination with gemcitabine + oxaliplatin (GEMOX) as a first-line treatment option for advanced BTC.

Methods: This prospective, single-arm, single-center study enrolled 35 patients with advanced BTC. The patients received toripalimab in combination with GEMOX as first-line treatment at Zhejiang Cancer Hospital, China, between February 2021 and April 2023. Each patient received 1 to 11 treatment cycles, and the objective response rate (ORR) was evaluated before and after chemotherapy using the Response Evaluation Criteria for Solid Tumors (RECIST) version 1.1. Progression-free survival (PFS) and overall survival (OS) were assessed using the Kaplan-Meier method. Furthermore, adverse events and their severity were recorded to evaluate the safety profile of the treatment.

Results: A study cohort of 35 patients was enrolled (median age, 57 years), including 15 men and 20 women. Of them, 18 had intrahepatic cholangiocarcinoma, 14 had gallbladder cancer, and 3 had hilar cholangiocarcinoma. Metastatic lesions were most commonly observed in the lymph nodes, liver, and pelvis. The ORR was 20% (95% confidence interval [CI] 8.4%-36.9%), including 2 for complete response (CR) and 5 for partial response (PR). The median PFS and OS were found to be 8.5 and 16.5 months, respectively. All patients experienced adverse events, with 11 (31.42%) of the patients having grade 3 or higher adverse events. The most commonly observed adverse events included increases in alanine aminotransferase (ALT) and aspartate aminotransferase (AST), leukopenia, neutropenia, and thrombocytopenia.

Conclusion: Toripalimab combined with GEMOX showed preliminary antitumor activity and an acceptable safety profile in patients with advanced BTC, warranting further validation in larger cohorts.

Clinical trial registration: Chinese Clinical Trial Registry (ChiCTR2600117154).

目的/背景:晚期胆道癌(BTC)是一种侵袭性恶性肿瘤,尽管标准化疗,但预后往往较差。本研究旨在评估托利帕单抗联合吉西他滨+奥沙利铂(GEMOX)作为晚期BTC一线治疗方案的初步疗效和安全性。方法:这项前瞻性、单臂、单中心研究纳入了35例晚期BTC患者。这些患者在2021年2月至2023年4月期间在中国浙江肿瘤医院接受了托帕里单抗联合GEMOX作为一线治疗。每例患者接受1 ~ 11个治疗周期,化疗前后采用实体瘤反应评价标准(RECIST) 1.1版评价客观缓解率(ORR)。采用Kaplan-Meier法评估无进展生存期(PFS)和总生存期(OS)。此外,记录不良事件及其严重程度,以评估治疗的安全性。结果:研究纳入了35例患者(中位年龄57岁),包括15名男性和20名女性。其中肝内胆管癌18例,胆囊癌14例,肝门胆管癌3例。转移性病变最常见于淋巴结、肝脏和骨盆。ORR为20%(95%可信区间[CI] 8.4%-36.9%),其中完全缓解(CR)为2,部分缓解(PR)为5。中位PFS和OS分别为8.5个月和16.5个月。所有患者均出现不良事件,11例(31.42%)患者出现3级及以上不良事件。最常见的不良反应包括谷丙转氨酶(ALT)和谷草转氨酶(AST)升高、白细胞减少、中性粒细胞减少和血小板减少。结论:torpalimab联合GEMOX在晚期BTC患者中显示出初步的抗肿瘤活性和可接受的安全性,需要在更大的队列中进一步验证。临床试验注册:中国临床试验注册中心(ChiCTR2600117154)。
{"title":"Preliminary Application of Toripalimab in Combination With GEMOX Regimen as a First-Line Treatment Option for Advanced Biliary Tract Tumors.","authors":"Meiqin Yuan, Wanxia Fang, Bixia Liu, Yahan Tong, Junchi Cheng, Haijun Zhong, Wangxia Lv","doi":"10.31083/BJHM50279","DOIUrl":"https://doi.org/10.31083/BJHM50279","url":null,"abstract":"<p><strong>Aims/background: </strong>Advanced biliary tract cancer (BTC) is an aggressive malignancy, and often presents with poor prognostic outcomes despite standard chemotherapy. This study aimed to evaluate the preliminary efficacy and safety of toripalimab in combination with gemcitabine + oxaliplatin (GEMOX) as a first-line treatment option for advanced BTC.</p><p><strong>Methods: </strong>This prospective, single-arm, single-center study enrolled 35 patients with advanced BTC. The patients received toripalimab in combination with GEMOX as first-line treatment at Zhejiang Cancer Hospital, China, between February 2021 and April 2023. Each patient received 1 to 11 treatment cycles, and the objective response rate (ORR) was evaluated before and after chemotherapy using the Response Evaluation Criteria for Solid Tumors (RECIST) version 1.1. Progression-free survival (PFS) and overall survival (OS) were assessed using the Kaplan-Meier method. Furthermore, adverse events and their severity were recorded to evaluate the safety profile of the treatment.</p><p><strong>Results: </strong>A study cohort of 35 patients was enrolled (median age, 57 years), including 15 men and 20 women. Of them, 18 had intrahepatic cholangiocarcinoma, 14 had gallbladder cancer, and 3 had hilar cholangiocarcinoma. Metastatic lesions were most commonly observed in the lymph nodes, liver, and pelvis. The ORR was 20% (95% confidence interval [CI] 8.4%-36.9%), including 2 for complete response (CR) and 5 for partial response (PR). The median PFS and OS were found to be 8.5 and 16.5 months, respectively. All patients experienced adverse events, with 11 (31.42%) of the patients having grade 3 or higher adverse events. The most commonly observed adverse events included increases in alanine aminotransferase (ALT) and aspartate aminotransferase (AST), leukopenia, neutropenia, and thrombocytopenia.</p><p><strong>Conclusion: </strong>Toripalimab combined with GEMOX showed preliminary antitumor activity and an acceptable safety profile in patients with advanced BTC, warranting further validation in larger cohorts.</p><p><strong>Clinical trial registration: </strong>Chinese Clinical Trial Registry (ChiCTR2600117154).</p>","PeriodicalId":9256,"journal":{"name":"British journal of hospital medicine","volume":"87 1","pages":"50279"},"PeriodicalIF":1.8,"publicationDate":"2026-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146084348","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Leadless Pacemakers: Clinical Advances, Outcomes, and Comparison With Conventional Systems. 无导线起搏器:临床进展、结果和与传统系统的比较。
IF 1.8 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-22 DOI: 10.31083/BJHM50278
Ibrahim Antoun, Alkassem Alkhayer, Riyaz Somani
{"title":"Leadless Pacemakers: Clinical Advances, Outcomes, and Comparison With Conventional Systems.","authors":"Ibrahim Antoun, Alkassem Alkhayer, Riyaz Somani","doi":"10.31083/BJHM50278","DOIUrl":"https://doi.org/10.31083/BJHM50278","url":null,"abstract":"","PeriodicalId":9256,"journal":{"name":"British journal of hospital medicine","volume":"87 1","pages":"50278"},"PeriodicalIF":1.8,"publicationDate":"2026-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146084361","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Case Report of the Unusual Presentation of the Left and Then the Right Spontaneous Carotid Artery Dissections Within 3 Weeks and a 7-Year Follow-Up. 1例罕见的自发性颈动脉左、右剥离3周及7年随访报告。
IF 1.8 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-20 DOI: 10.31083/BJHM50186
Vritika Ravisangar, Aravinth Sivagnanaratnam

Aims/background: Bilateral spontaneous carotid artery dissections are rare, comprising only 10% of spontaneous carotid artery dissection cases. They occur when there is a tear in the innermost lining of the artery called the tunica intima. An intramural hematoma may form which can lead to vessel lumen narrowing or occlusion, causing an acute ischaemic stroke.

Case presentation: We present a case of a man in his 50s with bilateral spontaneous internal carotid artery dissection who presented with a sudden onset of headache, neck pain, and right arm weakness. After being treated, the patient presented again after 3 weeks with neck pain on the right side, headache, and transient left arm weakness. He was treated with anticoagulation followed by antiplatelet therapy.

Results: At 6 months, the computed tomography angiogram (CTA) of carotid and vertebral arteries showed a largely resolved left internal carotid artery dissection (ICAD) and a resolved right ICAD. At the 7 years follow up, the patient continues to do well as he has not had any more transient ischaemic attacks or strokes.

Conclusion: This case demonstrates that carotid artery dissections should be considered when a patient presents with these symptoms, even if they present bilaterally in a short period, and can be investigated with a CTA or magnetic resonance angiogram, with treatment by antiplatelets or anticoagulation.

目的/背景:双侧自发性颈动脉夹层是罕见的,仅占自发性颈动脉夹层病例的10%。当动脉最内层被称为内膜撕裂时,就会出现这种情况。内壁血肿可导致血管腔狭窄或闭塞,引起急性缺血性中风。病例介绍:我们报告一例50多岁的男性,双侧自发性颈内动脉夹层,表现为突然发作的头痛、颈部疼痛和右臂无力。治疗后,患者3周后再次出现右侧颈部疼痛、头痛和一过性左臂无力。他接受了抗凝治疗和抗血小板治疗。结果:6个月时,颈动脉和椎动脉ct血管造影(CTA)显示左侧颈内动脉夹层(ICAD)基本溶解,右侧颈内动脉夹层(ICAD)基本溶解。在7年的随访中,患者继续表现良好,因为他没有再发生过短暂性缺血性发作或中风。结论:本病例表明,当患者出现这些症状时,即使是在短时间内双侧出现,也应考虑颈动脉夹层,可以通过CTA或磁共振血管造影进行检查,并接受抗血小板或抗凝治疗。
{"title":"A Case Report of the Unusual Presentation of the Left and Then the Right Spontaneous Carotid Artery Dissections Within 3 Weeks and a 7-Year Follow-Up.","authors":"Vritika Ravisangar, Aravinth Sivagnanaratnam","doi":"10.31083/BJHM50186","DOIUrl":"https://doi.org/10.31083/BJHM50186","url":null,"abstract":"<p><strong>Aims/background: </strong>Bilateral spontaneous carotid artery dissections are rare, comprising only 10% of spontaneous carotid artery dissection cases. They occur when there is a tear in the innermost lining of the artery called the tunica intima. An intramural hematoma may form which can lead to vessel lumen narrowing or occlusion, causing an acute ischaemic stroke.</p><p><strong>Case presentation: </strong>We present a case of a man in his 50s with bilateral spontaneous internal carotid artery dissection who presented with a sudden onset of headache, neck pain, and right arm weakness. After being treated, the patient presented again after 3 weeks with neck pain on the right side, headache, and transient left arm weakness. He was treated with anticoagulation followed by antiplatelet therapy.</p><p><strong>Results: </strong>At 6 months, the computed tomography angiogram (CTA) of carotid and vertebral arteries showed a largely resolved left internal carotid artery dissection (ICAD) and a resolved right ICAD. At the 7 years follow up, the patient continues to do well as he has not had any more transient ischaemic attacks or strokes.</p><p><strong>Conclusion: </strong>This case demonstrates that carotid artery dissections should be considered when a patient presents with these symptoms, even if they present bilaterally in a short period, and can be investigated with a CTA or magnetic resonance angiogram, with treatment by antiplatelets or anticoagulation.</p>","PeriodicalId":9256,"journal":{"name":"British journal of hospital medicine","volume":"87 1","pages":"50186"},"PeriodicalIF":1.8,"publicationDate":"2026-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146084280","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Changing Landscape for Hyper-Acute Ischaemic Stroke Care. 超急性缺血性卒中护理的变化前景。
IF 1.8 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-20 DOI: 10.31083/BJHM50187
Ajay Bhalla, Martin James

Delivery of reperfusion therapies such as thrombolysis and mechanical thrombectomy have revolutionised the treatment for acute ischaemic stroke with reduction in disability and mortality. Extended time windows for thrombolysis for patients presenting beyond 4.5 hours including wake up stroke have now increased the eligibility for these treatments. Tenecteplase has emerged as alternative thrombolytic agent to alteplase, with practical advantages. Mechanical thrombectomy is now available to a wider group of patients than previously considered such as patients presenting beyond 6 hours up to 24 hours, those with large core anterior circulation infarcts and posterior circulation stroke. Advances in brain imaging and their application to determine salvageable brain tissue is crucial in delivery of these interventions. Systems of care to enhance the delivery of these time critical treatments such as pre-hospital video triage and mobile stroke units may play a vital role in maximising population benefits from high-quality hyper-acute stroke care. The purpose of this review is to highlight the expansion of evidence for acute therapeutic interventions for ischaemic stroke and technologies to facilitate their delivery.

再灌注治疗的实施,如溶栓和机械取栓,彻底改变了急性缺血性卒中的治疗,减少了残疾和死亡率。包括醒脑卒中在内的超过4.5小时的患者的溶栓时间窗口延长,现在增加了这些治疗的资格。Tenecteplase已成为替代阿替普酶的溶栓药物,具有实用优势。机械取栓术现在可用于比以前考虑的更广泛的患者群体,例如出现时间超过6小时至24小时的患者,有较大核心前循环梗死和后循环卒中的患者。脑成像技术的进步及其在确定可抢救脑组织方面的应用对这些干预措施的实施至关重要。加强院前视频分诊和流动卒中单元等时间紧迫治疗的护理系统,可能在最大限度地提高人群从高质量超急性卒中护理中获益方面发挥至关重要的作用。本综述的目的是强调缺血性卒中急性治疗干预措施的证据扩展和促进其实施的技术。
{"title":"The Changing Landscape for Hyper-Acute Ischaemic Stroke Care.","authors":"Ajay Bhalla, Martin James","doi":"10.31083/BJHM50187","DOIUrl":"https://doi.org/10.31083/BJHM50187","url":null,"abstract":"<p><p>Delivery of reperfusion therapies such as thrombolysis and mechanical thrombectomy have revolutionised the treatment for acute ischaemic stroke with reduction in disability and mortality. Extended time windows for thrombolysis for patients presenting beyond 4.5 hours including wake up stroke have now increased the eligibility for these treatments. Tenecteplase has emerged as alternative thrombolytic agent to alteplase, with practical advantages. Mechanical thrombectomy is now available to a wider group of patients than previously considered such as patients presenting beyond 6 hours up to 24 hours, those with large core anterior circulation infarcts and posterior circulation stroke. Advances in brain imaging and their application to determine salvageable brain tissue is crucial in delivery of these interventions. Systems of care to enhance the delivery of these time critical treatments such as pre-hospital video triage and mobile stroke units may play a vital role in maximising population benefits from high-quality hyper-acute stroke care. The purpose of this review is to highlight the expansion of evidence for acute therapeutic interventions for ischaemic stroke and technologies to facilitate their delivery.</p>","PeriodicalId":9256,"journal":{"name":"British journal of hospital medicine","volume":"87 1","pages":"50187"},"PeriodicalIF":1.8,"publicationDate":"2026-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146084311","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring Causal Effects of Sarcopenia on Chronic Obstructive Pulmonary Disease and Hospitalization Risk: A Bi-Directional Mendelian Randomization Study. 探讨肌肉减少症与慢性阻塞性肺疾病和住院风险的因果关系:一项双向孟德尔随机研究。
IF 1.8 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-19 DOI: 10.31083/BJHM50164
Shikun Ni, Xin Lin, Zhibin Kong

Aims/background: As the global population ages, age-related chronic obstructive pulmonary disease (COPD) and sarcopenia present significant clinical and economic concerns. Emerging evidence suggests that these conditions are interrelated; however, potential confounding factors may impact observational investigations. Therefore, this study employed a bi-directional Mendelian randomization analysis to systematically investigate the causal relationship-rather than merely conducting a correlation analysis, between sarcopenia-related traits and COPD and hospitalization risk.

Methods: Univariate, two-sample, and bi-directional Mendelian randomization (MR) analyses were performed using data from genome-wide association studies. The data on Sarcopenia features, including appendicular lean mass (ALM), hand grip strength (HGS), usual walking pace (UWP), and moderate-to-vigorous physical activity (MVPA) were acquired from the UK Biobank. However, data on COPD and hospitalization risk were sourced from the FinnGen consortium. Inverse-variance weighted (IVW) MR and sensitivity analyses were performed to evaluate causal relationships. Additionally, the observed findings were validated using an independent COPD dataset sourced from the UK Biobank.

Results: The forward MR analysis using IVW revealed a significant negative causality between ALM, HGS, UWP, MVPA, and COPD (all p < 0.05, all pFDR < 0.05) (False Discovery Rate, FDR), as well as with COPD-related hospitalization (all p < 0.05, all pFDR < 0.05). These findings were corroborated by validation analyses. Furthermore, reverse MR assessment demonstrated that COPD alleviates UWP (p = 0.001, pFDR = 0.015); however, validation analysis did not confirm this result. Moreover, additional MR analyses yielded similar trends in causal relationships as evidenced by robust sensitivity tests.

Conclusion: Our study supported a unidirectional, negative causality between sarcopenia-related traits and COPD and hospitalization risk. This provides possible evidence that sarcopenia increases the risk of COPD and hospitalization at the genetic level. Our findings suggest that improving sarcopenia may serve as a promising strategy for minimizing the incidence of COPD and hospitalization risk, thereby reducing the health burden on these patients.

目的/背景:随着全球人口老龄化,与年龄相关的慢性阻塞性肺疾病(COPD)和肌肉减少症引起了重大的临床和经济问题。新出现的证据表明,这些情况是相互关联的;然而,潜在的混杂因素可能会影响观察性调查。因此,本研究采用双向孟德尔随机化分析,系统探讨肌少症相关特征与COPD及住院风险之间的因果关系,而不仅仅是进行相关性分析。方法:使用全基因组关联研究的数据进行单变量、双样本和双向孟德尔随机化(MR)分析。肌肉减少症的特征数据,包括附件瘦质量(ALM)、握力(HGS)、通常步行速度(UWP)和中等到剧烈的身体活动(MVPA),均从英国生物银行获得。然而,COPD和住院风险的数据来自FinnGen联盟。采用反方差加权MR (IVW)和敏感性分析来评估因果关系。此外,使用来自UK Biobank的独立COPD数据集验证了观察到的结果。结果:采用IVW进行正向MR分析,发现ALM、HGS、UWP、MVPA与COPD(均p < 0.05,均pFDR < 0.05) (False Discovery Rate, FDR)及COPD相关住院(均p < 0.05,均pFDR < 0.05)呈显著负相关因果关系。这些发现被验证分析证实。此外,反向MR评估显示COPD减轻了UWP (p = 0.001, pFDR = 0.015);然而,验证分析并没有证实这一结果。此外,额外的核磁共振分析得出了类似的因果关系趋势,如强有力的敏感性测试所证明的那样。结论:我们的研究支持肌肉减少症相关特征与COPD和住院风险之间单向负相关的因果关系。这为骨骼肌减少症在遗传水平上增加COPD和住院的风险提供了可能的证据。我们的研究结果表明,改善肌肉减少症可能是降低COPD发病率和住院风险的一种有希望的策略,从而减轻这些患者的健康负担。
{"title":"Exploring Causal Effects of Sarcopenia on Chronic Obstructive Pulmonary Disease and Hospitalization Risk: A Bi-Directional Mendelian Randomization Study.","authors":"Shikun Ni, Xin Lin, Zhibin Kong","doi":"10.31083/BJHM50164","DOIUrl":"https://doi.org/10.31083/BJHM50164","url":null,"abstract":"<p><strong>Aims/background: </strong>As the global population ages, age-related chronic obstructive pulmonary disease (COPD) and sarcopenia present significant clinical and economic concerns. Emerging evidence suggests that these conditions are interrelated; however, potential confounding factors may impact observational investigations. Therefore, this study employed a bi-directional Mendelian randomization analysis to systematically investigate the causal relationship-rather than merely conducting a correlation analysis, between sarcopenia-related traits and COPD and hospitalization risk.</p><p><strong>Methods: </strong>Univariate, two-sample, and bi-directional Mendelian randomization (MR) analyses were performed using data from genome-wide association studies. The data on Sarcopenia features, including appendicular lean mass (ALM), hand grip strength (HGS), usual walking pace (UWP), and moderate-to-vigorous physical activity (MVPA) were acquired from the UK Biobank. However, data on COPD and hospitalization risk were sourced from the FinnGen consortium. Inverse-variance weighted (IVW) MR and sensitivity analyses were performed to evaluate causal relationships. Additionally, the observed findings were validated using an independent COPD dataset sourced from the UK Biobank.</p><p><strong>Results: </strong>The forward MR analysis using IVW revealed a significant negative causality between ALM, HGS, UWP, MVPA, and COPD (all <i>p</i> < 0.05, all <i>p</i><sub>FDR</sub> < 0.05) (False Discovery Rate, FDR), as well as with COPD-related hospitalization (all <i>p</i> < 0.05, all <i>p</i><sub>FDR</sub> < 0.05). These findings were corroborated by validation analyses. Furthermore, reverse MR assessment demonstrated that COPD alleviates UWP (<i>p</i> = 0.001, <i>p</i><sub>FDR</sub> = 0.015); however, validation analysis did not confirm this result. Moreover, additional MR analyses yielded similar trends in causal relationships as evidenced by robust sensitivity tests.</p><p><strong>Conclusion: </strong>Our study supported a unidirectional, negative causality between sarcopenia-related traits and COPD and hospitalization risk. This provides possible evidence that sarcopenia increases the risk of COPD and hospitalization at the genetic level. Our findings suggest that improving sarcopenia may serve as a promising strategy for minimizing the incidence of COPD and hospitalization risk, thereby reducing the health burden on these patients.</p>","PeriodicalId":9256,"journal":{"name":"British journal of hospital medicine","volume":"87 1","pages":"50164"},"PeriodicalIF":1.8,"publicationDate":"2026-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146084185","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Demystifying Tracheostomies. 阐明气管造口术。
IF 1.8 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-19 DOI: 10.31083/BJHM50155
Hayaka Amada, Thomas Thornton, Ned Gilbert-Kawai

Tracheostomy insertion is becoming increasingly common in the UK. As patients with tracheostomies may be encountered in any healthcare setting, it is vital that doctors of all grades and specialties are familiar with the basic components of a tracheostomy and their management. This article aims to 'demystify' tracheostomies to enable the reader to feel more confident and competent at managing these patients in their clinical practice.

气管切开术在英国越来越普遍。由于气管切开术患者可能在任何医疗机构中遇到,因此所有级别和专业的医生熟悉气管切开术的基本组成部分及其管理是至关重要的。本文旨在“揭开”气管切开术的神秘面纱,使读者在临床实践中更有信心和能力管理这些患者。
{"title":"Demystifying Tracheostomies.","authors":"Hayaka Amada, Thomas Thornton, Ned Gilbert-Kawai","doi":"10.31083/BJHM50155","DOIUrl":"https://doi.org/10.31083/BJHM50155","url":null,"abstract":"<p><p>Tracheostomy insertion is becoming increasingly common in the UK. As patients with tracheostomies may be encountered in any healthcare setting, it is vital that doctors of all grades and specialties are familiar with the basic components of a tracheostomy and their management. This article aims to 'demystify' tracheostomies to enable the reader to feel more confident and competent at managing these patients in their clinical practice.</p>","PeriodicalId":9256,"journal":{"name":"British journal of hospital medicine","volume":"87 1","pages":"50155"},"PeriodicalIF":1.8,"publicationDate":"2026-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146084221","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Airway Microbiome in Chronic Obstructive Pulmonary Disease (COPD): A Guide for Clinicians. 慢性阻塞性肺疾病(COPD)的气道微生物组:临床医生指南。
IF 1.8 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-19 DOI: 10.31083/BJHM50163
Wei Ling Yolanda Koo, Kai Xian Thng, Pei Yee Tiew, Sanjay H Chotirmall

Chronic obstructive pulmonary disease (COPD) is a progressive and debilitating respiratory condition marked by chronic symptoms and frequent exacerbations, contributing to significant morbidity and mortality. The advent of molecular microbiology and next-generation sequencing (NGS) has expanded our understanding of the lung microbiome, and integration of microbiome datasets with other omics reveals important microbial-metabolic-immuno-inflammatory interactions that influence COPD pathogenesis. Recent studies have highlighted dysbiosis of the airway microbiome, with shifts in bacterial, viral, and fungal communities playing a crucial role in disease progression, exacerbations and clinical outcomes. Moreover, microbiome changes are observed in COPD associated overlap syndromes, complicating diagnosis and treatment. This review synthesizes current microbiome research in COPD, focusing on its clinical relevance, including its potential as a diagnostic and prognostic tool. We additionally discuss the challenges of integrating microbiome data into clinical practice, emphasizing the need for personalized, precision medicine approaches to optimize COPD management and improve patient outcomes.

慢性阻塞性肺疾病(COPD)是一种以慢性症状和频繁恶化为特征的进行性和衰弱性呼吸系统疾病,导致严重的发病率和死亡率。分子微生物学和下一代测序(NGS)的出现扩大了我们对肺微生物组的理解,微生物组数据集与其他组学的整合揭示了影响COPD发病机制的重要微生物-代谢-免疫-炎症相互作用。最近的研究强调了气道微生物群的生态失调,细菌、病毒和真菌群落的变化在疾病进展、恶化和临床结果中起着至关重要的作用。此外,在COPD相关重叠综合征中观察到微生物组变化,使诊断和治疗复杂化。本综述综合了目前COPD中微生物组的研究,重点关注其临床相关性,包括其作为诊断和预后工具的潜力。我们还讨论了将微生物组数据整合到临床实践中的挑战,强调需要个性化、精准医学方法来优化COPD管理和改善患者预后。
{"title":"The Airway Microbiome in Chronic Obstructive Pulmonary Disease (COPD): A Guide for Clinicians.","authors":"Wei Ling Yolanda Koo, Kai Xian Thng, Pei Yee Tiew, Sanjay H Chotirmall","doi":"10.31083/BJHM50163","DOIUrl":"https://doi.org/10.31083/BJHM50163","url":null,"abstract":"<p><p>Chronic obstructive pulmonary disease (COPD) is a progressive and debilitating respiratory condition marked by chronic symptoms and frequent exacerbations, contributing to significant morbidity and mortality. The advent of molecular microbiology and next-generation sequencing (NGS) has expanded our understanding of the lung microbiome, and integration of microbiome datasets with other omics reveals important microbial-metabolic-immuno-inflammatory interactions that influence COPD pathogenesis. Recent studies have highlighted dysbiosis of the airway microbiome, with shifts in bacterial, viral, and fungal communities playing a crucial role in disease progression, exacerbations and clinical outcomes. Moreover, microbiome changes are observed in COPD associated overlap syndromes, complicating diagnosis and treatment. This review synthesizes current microbiome research in COPD, focusing on its clinical relevance, including its potential as a diagnostic and prognostic tool. We additionally discuss the challenges of integrating microbiome data into clinical practice, emphasizing the need for personalized, precision medicine approaches to optimize COPD management and improve patient outcomes.</p>","PeriodicalId":9256,"journal":{"name":"British journal of hospital medicine","volume":"87 1","pages":"50163"},"PeriodicalIF":1.8,"publicationDate":"2026-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146084377","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prognostic Factors of Staphylococcus aureus Bloodstream Infection in ICU Patients and Establishment of a Prediction Model. ICU患者金黄色葡萄球菌血流感染的预后因素及预测模型的建立。
IF 1.8 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-19 DOI: 10.31083/BJHM50154
Dongmei Li, Maximilian de Courten, Bo He, Peng Shen, Qing Gao, Chongge Yang, Yongzhe Zhang, Qiaoxin Shi

Aims/background: Staphylococcus aureus bacteremia (SAB) bloodstream infection (BSI) is a common complication among patients treated in the intensive care unit (ICU), predisposing them to high morbidity and mortality. The mortality rate at one and three months is 18% and 27%, respectively, and the recurrence and reinfection rate reaches 9%. This study aims to analyze prognostic factors for ICU patients with SAB BSI and establish a prediction model.

Methods: A total of 210 SAB BSI patients admitted to the ICU from January 2020 to December 2023 were retrospectively selected. Patients were randomly divided in a 3:2 ratio into a modeling group (n = 126) and a validation group (n = 84). Within the modeling group, patients were further categorized into the good prognosis group (n = 75) and the poor prognosis group (n = 51) based on their prognosis outcomes. Univariate and binary logistic regression analyses were conducted to identify prognostic factors for SAB BSI patients. A prediction model was constructed using SPSS, receiver operating characteristic (ROC) curves were generated with R programming language, and calibration and decision curve analysis (DCA) curves were utilized to assess the model's application value.

Results: Inappropriate initial antibiotic therapy, infection source, Acute Physiology and Chronic Health Evaluation II (APACHE II) score, and central venous catheter placement showed significant differences (p < 0.05). The results of binary logistic regression analysis indicated that inappropriate initial antibiotic therapy, infection source, APACHE II score, and central venous catheter placement were prognostic factors for SAB BSI patients (p < 0.05). The model equation was Logit(P) = -3.549 + (0.871X1) + (0.959X2) + (0.070X3) + (0.832X4). The model in the modeling group and the validation group showed a calibration curve with a slope close to 1, which indicates good consistency between the predicted risk and the actual risk. The ROC analysis results indicated that in the validation group, the model had an area under the curve of 0.7857 with a standard error of 0.0331 (95% confidence interval (CI): 0.7229-0.8518, p < 0.001) and a Youden's index of 0.61, resulting in a sensitivity of 80.96% and a specificity of 79.64%. The decision curve analysis (DCA) curve demonstrated that the model had a clear positive net benefit.

Conclusion: Inappropriate initial antibiotic therapy, infection source, APACHE II score, and central venous catheter placement are prognostic factors for SAB BSI patients receiving care in the ICU. This study successfully established and validated a prediction model for SAB BSI.

目的/背景:金黄色葡萄球菌菌血症(SAB)血流感染(BSI)是重症监护病房(ICU)治疗患者的常见并发症,使其易患高发病率和死亡率。1个月和3个月死亡率分别为18%和27%,复发率和再感染率达9%。本研究旨在分析ICU患者SAB BSI的预后因素,并建立预测模型。方法:回顾性选择2020年1月至2023年12月ICU收治的210例SAB BSI患者。将患者按3:2的比例随机分为建模组126例和验证组84例。在造模组内,根据预后情况将患者进一步分为预后良好组(n = 75)和预后不良组(n = 51)。进行单因素和二元logistic回归分析,以确定SAB BSI患者的预后因素。采用SPSS软件构建预测模型,用R编程语言生成受试者工作特征(ROC)曲线,并利用标定曲线和决策曲线分析(DCA)曲线评估模型的应用价值。结果:初始抗生素治疗不当、感染源、急性生理与慢性健康评估II (Acute Physiology and Chronic Health Evaluation II, APACHE II)评分、中心静脉置管差异有统计学意义(p < 0.05)。二元logistic回归分析结果显示,不适当的初始抗生素治疗、感染源、APACHE II评分、中心静脉置管是影响SAB BSI患者预后的因素(p < 0.05)。模型方程为Logit(P) = -3.549 + (0.871X1) + (0.959X2) + (0.070X3) + (0.832X4)。建模组和验证组模型的校正曲线斜率接近1,说明预测风险与实际风险一致性较好。ROC分析结果显示,验证组模型曲线下面积为0.7857,标准误差为0.0331(95%可信区间(CI): 0.7229-0.8518, p < 0.001),约登指数为0.61,敏感性为80.96%,特异性为79.64%。决策曲线分析(DCA)曲线表明,该模型具有明显的正净效益。结论:不适当的初始抗生素治疗、感染源、APACHE II评分和中心静脉置管是SAB BSI患者在ICU接受治疗的预后因素。本研究成功建立并验证了SAB BSI预测模型。
{"title":"Prognostic Factors of <i>Staphylococcus aureus</i> Bloodstream Infection in ICU Patients and Establishment of a Prediction Model.","authors":"Dongmei Li, Maximilian de Courten, Bo He, Peng Shen, Qing Gao, Chongge Yang, Yongzhe Zhang, Qiaoxin Shi","doi":"10.31083/BJHM50154","DOIUrl":"https://doi.org/10.31083/BJHM50154","url":null,"abstract":"<p><strong>Aims/background: </strong><i>Staphylococcus aureus</i> bacteremia (SAB) bloodstream infection (BSI) is a common complication among patients treated in the intensive care unit (ICU), predisposing them to high morbidity and mortality. The mortality rate at one and three months is 18% and 27%, respectively, and the recurrence and reinfection rate reaches 9%. This study aims to analyze prognostic factors for ICU patients with SAB BSI and establish a prediction model.</p><p><strong>Methods: </strong>A total of 210 SAB BSI patients admitted to the ICU from January 2020 to December 2023 were retrospectively selected. Patients were randomly divided in a 3:2 ratio into a modeling group (<i>n</i> = 126) and a validation group (<i>n</i> = 84). Within the modeling group, patients were further categorized into the good prognosis group (<i>n</i> = 75) and the poor prognosis group (<i>n</i> = 51) based on their prognosis outcomes. Univariate and binary logistic regression analyses were conducted to identify prognostic factors for SAB BSI patients. A prediction model was constructed using SPSS, receiver operating characteristic (ROC) curves were generated with R programming language, and calibration and decision curve analysis (DCA) curves were utilized to assess the model's application value.</p><p><strong>Results: </strong>Inappropriate initial antibiotic therapy, infection source, Acute Physiology and Chronic Health Evaluation II (APACHE II) score, and central venous catheter placement showed significant differences (<i>p</i> < 0.05). The results of binary logistic regression analysis indicated that inappropriate initial antibiotic therapy, infection source, APACHE II score, and central venous catheter placement were prognostic factors for SAB BSI patients (<i>p</i> < 0.05). The model equation was Logit(P) = -3.549 + (0.871X<sub>1</sub>) + (0.959X<sub>2</sub>) + (0.070X<sub>3</sub>) + (0.832X<sub>4</sub>). The model in the modeling group and the validation group showed a calibration curve with a slope close to 1, which indicates good consistency between the predicted risk and the actual risk. The ROC analysis results indicated that in the validation group, the model had an area under the curve of 0.7857 with a standard error of 0.0331 (95% confidence interval (CI): 0.7229-0.8518, <i>p</i> < 0.001) and a Youden's index of 0.61, resulting in a sensitivity of 80.96% and a specificity of 79.64%. The decision curve analysis (DCA) curve demonstrated that the model had a clear positive net benefit.</p><p><strong>Conclusion: </strong>Inappropriate initial antibiotic therapy, infection source, APACHE II score, and central venous catheter placement are prognostic factors for SAB BSI patients receiving care in the ICU. This study successfully established and validated a prediction model for SAB BSI.</p>","PeriodicalId":9256,"journal":{"name":"British journal of hospital medicine","volume":"87 1","pages":"50154"},"PeriodicalIF":1.8,"publicationDate":"2026-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146084326","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Management of Kidney Stone Disease. 肾结石疾病的处理。
IF 1.8 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-14 DOI: 10.31083/BJHM50000
Elisha Ogbodo, Patrick Juliebø-Jones, Bhaskar K Somani

Kidney stone disease (KSD) is a common urological condition. For the patient, it typically presents with severe colicky flank pain and can have a substantial impact on quality of life, work productivity, and livelihood. For the clinician, they can present a diagnostic conundrum particularly in the absence of appropriate imaging, and the cost burden to the healthcare system can be significant. Investigations serve to rule out underlying metabolic, structural or pathological abnormalities, as well as identify the size, number, location, type and associated features of stone. KSD treatment can be complex, encompassing a spectrum of conservative, dietary, medical, and surgical approaches. This article provides an overview of the risk factors, clinical features, diagnosis, prevention and management of KSD. We conclude with a review of the recent innovations in this field.

肾结石病(KSD)是一种常见的泌尿系统疾病。对于患者来说,它通常表现为严重的腹绞痛性疼痛,并可能对生活质量、工作效率和生计产生重大影响。对于临床医生来说,他们可能会提出一个诊断难题,特别是在缺乏适当的成像的情况下,医疗保健系统的成本负担可能是显著的。检查有助于排除潜在的代谢、结构或病理异常,以及确定结石的大小、数量、位置、类型和相关特征。KSD的治疗可能很复杂,包括保守、饮食、药物和手术方法。本文就KSD的危险因素、临床特点、诊断、预防和治疗作一综述。最后,我们回顾了这一领域最近的创新。
{"title":"Management of Kidney Stone Disease.","authors":"Elisha Ogbodo, Patrick Juliebø-Jones, Bhaskar K Somani","doi":"10.31083/BJHM50000","DOIUrl":"https://doi.org/10.31083/BJHM50000","url":null,"abstract":"<p><p>Kidney stone disease (KSD) is a common urological condition. For the patient, it typically presents with severe colicky flank pain and can have a substantial impact on quality of life, work productivity, and livelihood. For the clinician, they can present a diagnostic conundrum particularly in the absence of appropriate imaging, and the cost burden to the healthcare system can be significant. Investigations serve to rule out underlying metabolic, structural or pathological abnormalities, as well as identify the size, number, location, type and associated features of stone. KSD treatment can be complex, encompassing a spectrum of conservative, dietary, medical, and surgical approaches. This article provides an overview of the risk factors, clinical features, diagnosis, prevention and management of KSD. We conclude with a review of the recent innovations in this field.</p>","PeriodicalId":9256,"journal":{"name":"British journal of hospital medicine","volume":"87 1","pages":"50000"},"PeriodicalIF":1.8,"publicationDate":"2026-01-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146084382","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
British journal of hospital medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1